COVID-19: Keep up to date with the latest pharmaceutical and healthcare news as the pandemic evolves

Silver linings and striving for gold

Jenny Ousbey, founder of OVID Health, on raising the bar for patient-centricity
Right, left and centre

Interest in our own health has grown exponentially in recent decades and COVID-19 has continued to highlight the increasing currency of disease knowledge. Our five panelists discuss the rise of Patient 2.0 and how pharma is successfully leveraging their experience and expertise
Customer engagement in the COVID-19 recovery era

Oli Hudson, content director at Wilmington Healthcare, explores how the coronavirus pandemic is changing pharma’s relationship with the NHS

News

View all

Keytruda/Lenvima combo shows promise in hard-to-treat cancers

Data shows a range of responses in different tumours

21st September 2020

University of Edinburgh spinout Cellinta will develop gene therapies for cancer

Investors include SV Health Investors and Cancer Research UK

21st September 2020

Lynparza scores long-term benefit data in BRCA-mutated ovarian cancer

Detailed results presented at ESMO also show benefit in prostate cancer

21st September 2020

CHMP backs seven new meds in September meeting

Positive opinions include Pacira's Exparel and two new vaccines from Sanofi

21st September 2020

BMS' Opdivo wins new NICE lung cancer backing

The drug has been approved for routine NHS commissioning for squamous or non-squamous NSCLC

18th September 2020

Web Exclusives

View all

What does creativity really mean in healthcare?

And why does it matter more than ever following COVID-19?

Mixing up the elements

Why the hybrid model is the way forward for live shows

Tackling the energy challenge

Three ways to optimise energy consumption in pharma manufacturing

A deal for pharma?

What does pharma have left to fight for in an EU trade deal?

Magazine

View more from the latest edition

Patient-centricity interview - Henry Featherstone

Henry Featherstone, Director of Public Affairs, Sanofi

Patient-centricity interview - Gareth Powell

Gareth Powell, Patient Engagement Project Lead, National Institute for Health Research (NIHR)

Patient-centricity interview - Peter Impey

Peter Impey, Managing Director, 90TEN Communications – part of the Envision Pharma group

Joseph Saba considers the affect of COVID-19 on access to healthcare

Controlling the rise of robots

Charlotte Walker-Osborn considers whether the law will be able to keep up with the rise of robots, drones and automated processes

A new endpoint for patients

Janssen's Joaquín Casariego says pharma can do more to ensure patients are truly front and centre

Customer engagement in the COVID-19 recovery era

Oli Hudson, content director at Wilmington Healthcare, explores how the coronavirus pandemic is changing pharma’s relationship with the NHS

Applying international best practice in diabetes care

Roche’s Michael Goetzl looks at global variations in the approach to managing diabetes, and the potential lessons for the UK

Thought Leadership

View all

The concordance conundrum – the tech divide

Consultations in a virtual world

Changing gear – how to take patient-centricity to the next level

Truly achieving a patient-focused cultural shift means pharma leaders must build momentum behind the necessity of partnering with patients to capture and incorporate their valuable insights, say Dawn Lobban and Peter Impey